Mario Castro, MD, MPH

Quick facts

Phase 2 pipeline

• Hyperpolarized Xe129 · Oncology
  Hyperpolarized Xe129 is a magnetic resonance imaging (MRI) contrast agent that enhances the visibility of tumors and other lesions.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Mario Castro, MD, MPH portfolio CI brief
• Mario Castro, MD, MPH pipeline updates RSS